Prevalence and clinical significance of a patent foramen ovale in patients with chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 100, Issue 5, 2006, Pages 903-910

  Hacievliyagil, Suleyman Savas ^a   Gunen, Hakan ^a   Kosar, Feridun M ^a   Sahin, Ibrahim ^a   Kilic, Talat ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Clinical significance; COPD; Patent foramen ovale; Prevalence

Indexed keywords

ADULT; AGED; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD GAS ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPOXEMIA; LOGISTIC REGRESSION ANALYSIS; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SPIROMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRANSTHORACIC ECHOCARDIOGRAPHY; VALSALVA MANEUVER; WALKING;

AGED; CONTRAST MEDIA; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE; MIDDLE AGED; OXIMETRY; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VALSALVA MANEUVER;

EID: 33645894465     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.08.015     Document Type: Article

References (23)

1. Shanoudy H., Soliman A., Raggi P., et al. Prevalence of patient foramen ovale and its contrubition to hypoxemia in patients with obstructive sleep apnea. Chest 113 (1998) 91-96
2. Hagen P.T., Scholz D.G., and Edwars W.D. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59 (1984) 17-20
3. Movsowitz C., Podolsky L.A., Meyerowitz C.B., et al. Patent foramen ovale: a nonfunctional embryological remnant or a potential cause of significant pathology?. J Am Soc Echocardiogr 5 (1992) 259-270
4. Lynch J.J., Schuchard G.H., Gross C.M., et al. Prevalence of right to left atrial shunting in a healthy population: detection by Valsalva maneuver contrast echocardiography. Am J Cardiol 53 (1984) 1478-1480
5. Sardesi S.H., Marshall R.J., and Mourant A.J. Paradoxical systemic embolization through a patent foramen ovale. Lancet 1 (1989) 732-733
6. Nootens M.T., Berarducci L.A., Kaufmann E., et al. The prevalence and significance of a patent foramen ovale in pulmonary hypertension. Chest 104 (1993) 1673-1675
7. Arquizan C., Coste J., Touboul P.J., and Mas J.L. Is patent foramen ovale a family trait? A Transcranial Doppler sonographic study. Stroke 32 (2001) 1563-1566
8. Schuchlenz H., Weihs W., Beitzke A., et al. Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke 33 (2002) 293-296
9. Soliman A., Shanoudy H., Liu J., et al. Increased prevalence of patent foramen ovale in patients with severe chronic obstructive pulmonary disease. J Am Soc Echocardiogr 12 (1999) 99-105
10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 152 (1995) S77-S121
11. Sahebjami H., and Sathianpitayakul E. Influence of body weight on the severity of dyspnea in COPD. Am J Respir Crit Care Med 161 (2000) 886-890
12. ATS Statement. Standardization of spirometry-1994 update. Am J Respir Crit Care Med 152 (1995) 1107-1136
13. Battle R., Davitt M.A., Cooper S.M., et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 110 (1996) 1515-1519
14. Lynch J.J., Schuchard G.H., Gross C.M., et al. Prevalence of right to left shunting in a healthy population: detection by Valsalva maneuver and contrast echocardiography. Am J Cardiol 53 (1984) 1478-1480
15. Mulvagh S.L., DeMaria A.N., Feinstein S.B., et al. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 13 (2000) 331-342
16. Gunen H., and Kosar F. Spirometric predictors for the exclusion of severe hypoxemia in chronic obstructive pulmonary disease. Can Respir J 8 (2001) 245-249
17. Pauwels R.A., Buist A.S., Calverley P.M., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
18. Marin J.M., Carrizo S.J., Gascon M., et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during 6-min-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 1395-1399
19. Mak V.H.F., Bugler J.R., Roberts C.M., and Spiro S.G. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax 48 (1993) 33-38
20. Rozkovec A., Montanes P., and Oakley C. Factors that influence the outcome of primary pulmonary hypertension. Br Hearth J 55 (1986) 449-458
21. Okubo S., Naito M., Nakanishi N., et al. Prognosis of primary pulmonary hypertension and its determinants. J Cardiol 18 (1988) 1097-1107
22. Glanville A.R., Burke C.M., Theodore J., and Robin E.D. Primary pulmonary hypertension: length of survival in patients referred for hearth-lung transplantation. Chest 91 (1987) 675-681
23. Fisher D.C., Fisher E.A., Budd J.H., et al. The incidence of patent foramen ovale in 1000 consecutive patients. A contrast transesophageal echocardiography study. Chest 107 (1995) 1504-1509